Discontinued Product

Unfortunately (R)-5-Bromowillardiine (Cat. No. 0303) has been withdrawn from sale for commercial reasons.
Cat.No. 0303 - (R)-5-Bromowillardiine | CAS No. 19674-75-0
Description: Inactive isomer of (0132)
Chemical Name: (R)-(+)-a-Amino-5-bromo-3,4-dihydro-2,4-dioxo-1(2H)pyridinepropanoic acid

Biological Activity

Inactive isomer of (RS)-5-bromowillardiine.

Technical Data

M. Wt 278.06
Storage Store at RT
CAS Number 19674-75-0

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

All Tocris products are intended for laboratory research use only.

Preparing Stock Solutions

The following data is based on the product molecular weight 278.06. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 3.6 mL 17.98 mL 35.96 mL
5 mM 0.72 mL 3.6 mL 7.19 mL
10 mM 0.36 mL 1.8 mL 3.6 mL
50 mM 0.07 mL 0.36 mL 0.72 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Product Datasheets

Certificate of Analysis is currently unavailable on-line.
Please contact Customer Service.
Safety Datasheet


References are publications that support the products' biological activity.

Patneau et al (1992) Activation and desensitization of AMPA/kainate receptors by novel derivatives of willardiine. J.Neurosci. 12 595 PMID: 1371315

Jane et al (1991) New willardiine analogues with potent stereoselective actions of mammalian spinal neurones. Br.J.Pharmacol. 104 333P PMID:

Keywords: (R)-5-Bromowillardiine, supplier, Non-selective, Ionotropic, Glutamate, Non-selective, Ionotropic, Glutamate, Tocris Bioscience

Citations for (R)-5-Bromowillardiine

Citations are publications that use Tocris products.

Currently there are no citations for (R)-5-Bromowillardiine.

Reviews for (R)-5-Bromowillardiine

There are currently no reviews for this product. Be the first to review (R)-5-Bromowillardiine and earn rewards!

Have you used (R)-5-Bromowillardiine?

Submit a review and receive an Amazon gift card.

$10US/$10CAN/€7/£6 gift card for a review without an image

$25US/$25CAN/€18/£15 gift card for a review with an image

*Offer only valid in the USA / Canada, UK and Europe

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Pain Research Product Guide

A collection of over 250 products for pain research, the guide includes research tools for the study of:

  • Nociception
  • Ion Channels
  • G-Protein-Coupled Receptors
  • Intracellular Signaling

Pain Poster

Peripheral sensitization is the reduction in the threshold of excitability of sensory neurons that results in an augmented response to a given external stimulus. This poster outlines the excitatory and inhibitory signaling pathways involved in modulation of peripheral sensitization. The role of ion channels, GPCRs, neurotrophins, and cytokines in sensory neurons are also described.


Parkinson's Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.